(ZeroHedge)—Artificial intelligence is spreading quickly through modern healthcare, promising to make medical treatment faster, more accurate, and more personalized. But as hospitals and manufacturers adopt the technology, safety records, lawsuits, and regulatory struggles suggest that the transition has not been smooth, a new investigation by Reuters shows.
One example involves Acclarent, a subsidiary of Johnson & Johnson, which added machine-learning software to its TruDi Navigation System in 2021. The company described the update as “a leap forward,” saying it would help ear, nose, and throat surgeons better guide their instruments during sinus procedures.
Before the AI upgrade, the device had generated only a handful of malfunction reports. In the years that followed, however, federal regulators received more than 100 reports involving technical failures…




